慢性冠心病女性PCI与CABG长期结局比较
该回顾性队列研究链接加拿大安大略省临床与行政数据库,纳入2012至2021年接受PCI或CABG的慢性严重冠心病女性,经倾向评分匹配后比较长期结局。中位随访5.1年时,PCI组主要不良心脑血管事件(MACCE)及全因死亡率均高于CABG组,提示在适当选择的女性中CABG或为更优血运重建策略。
要点
- 慢性严重冠心病女性中,PCI组MACCE风险高于CABG组(HR 1.81)。
- PCI组全因死亡率高于CABG组(HR 1.34)。
- PCI组心血管再入院风险高于CABG组(HR 1.40)。
核心结论
- 在慢性严重冠心病女性中,与PCI相比,CABG与长期MACCE和全因死亡率降低相关。
- 研究结果支持在适当选择的女性中将CABG视为首选血运重建策略。
研究设计与样本
- 倾向评分匹配的回顾性队列研究,链接加拿大安大略省临床与行政数据库。
- 纳入2012至2021年接受PCI或CABG的慢性严重冠心病女性。
- 共2469例接受PCI、3721例接受CABG,倾向评分匹配后得到2033对均衡配对。
- 患者平均(±SD)年龄为66.5(±8.6)岁。
- 采用Cox比例风险模型评估结局。
主要发现
- 中位随访5.1年(四分位距2.9-7.5年)时,PCI组MACCE高于CABG组(HR 1.81,95%CI 1.63-2.01,P < .001)。
- PCI组全因死亡率高于CABG组(HR 1.34,95%CI 1.16-1.54,P < .001)。
- PCI组心血管再入院(MI、HF或卒中)高于CABG组(HR 1.40,95%CI 1.32-1.49,P < .001)。
临床怎么用
- 在慢性严重冠心病女性中,应结合个体情况考虑CABG作为血运重建的优先选择。
- 与PCI相比,CABG可能降低长期MACCE和全因死亡风险,决策时需权衡。
局限性
- 研究为回顾性队列设计,即便经倾向评分匹配仍可能存在残余混杂。
- 研究基于加拿大安大略省数据库,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Real-world evidence comparing percutaneous coronary intervention (PCI) to coronary artery bypass grafting (CABG) in women with chronic severe coronary artery disease (CAD) is limited. This study aimed to compare long-term outcomes of PCI and CABG in women with chronic severe CAD. METHODS: This propensity score-matched retrospective cohort study linked clinical and administrative databases in Ontario, Canada to identify women with chronic severe CAD undergoing PCI or CABG from 2012 to 2021. Major adverse cardiovascular and cerebrovascular events (MACCE), defined as a composite of all-cause mortality, myocardial infarction (MI), stroke, or repeat revascularization, as well as the individual components of MACCE and cardiovascular readmission (MI, heart failure [HF], or stroke), were evaluated using the Cox proportional hazards model. RESULTS: A total of 2469 and 3721 women underwent PCI and CABG, respectively. After propensity score matching, 2033 well-balanced pairs were identified. The mean (±SD) age of patients was 66.5 (±8.6) years. At a median follow-up of 5.1 (inter-quartile range: 2.9-7.5) years, MACCE was higher with PCI compared with CABG (hazard ratio [HR] 1.81, 95% confidence interval [CI]: 1.63-2.01], P < .001). All-cause mortality was higher with PCI compared with CABG (HR 1.34 [95% CI: 1.16-1.54], P < .001). Cardiovascular readmission (MI, HF, or stroke) was higher with PCI compared with CABG (HR 1.40 [95% CI: 1.32-1.49], P < .001). CONCLUSIONS: In women with chronic severe CAD, CABG appears to be associated with a long-term reduction in MACCE and all-cause mortality compared with PCI. These findings support consideration of CABG as the preferred revascularization strategy in appropriately selected women.
引用
- An KR, Vervoort D, Qiu F, et al. Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting. Eur Heart J. 2026. PMID: 41288359. doi:10.1093/eurheartj/ehaf806
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。